Retinopathy of prematurity (Q60439193)

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Increased 36-week survival with high oxygen saturation target in extremely preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity: current concepts in molecular pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Understanding retinopathy of prematurity: update on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

A paradigm shift in the prevention of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Mediators involved in retinopathy of prematurity and emerging therapeutic targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Perinatal infection, inflammation, and retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Mechanisms and management of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Epidemiology and causes of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Early death, morbidity, and need of treatment among extremely premature infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Threshold retinopathy at threshold of viability: the EpiBel study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Prenatal Risk Factors for Severe Retinopathy of Prematurity Among Very Preterm Infants of the Australian and New Zealand Neonatal Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Mortality and morbidity in extremely preterm infants (22 to 26 weeks of gestation): Austria 1999-2001

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

No improvement in outcome of nationwide extremely low birth weight infant populations between 1996-1997 and 1999-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Trends in outcomes for very preterm infants in the southern region of Sweden over a 10-year period.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity in the UK I: the organisation of services for screening and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Swedish national register for retinopathy of prematurity (SWEDROP) and the evaluation of screening in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Trends in the incidence of severe retinopathy of prematurity in a geographically defined population over a 10-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Incidence of retinopathy of prematurity in the United States: 1997 through 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Capacity building of nurses providing neonatal care in Rio de Janeiro, Brazil: methods for the POINTS of care project to enhance nursing education and reduce adverse neonatal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Pathological basis of retrolental fibroplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Aggressive posterior retinopathy of prematurity in large preterm babies in South India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The neurovascular retina in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Screening for Retinopathy of Prematurity in Infants Born Before 27 Weeks' Gestation in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Placenta microbiology and histology and the risk for severe retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Further observations on cost of preventing retrolental fibroplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity and pulse oximetry: a national survey of recent practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Oxygen-saturation targets and outcomes in extremely preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The progression of retinopathy of prematurity and fluctuation in blood gas tension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Transcutaneous oxygen levels in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO₂technology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Is being small for gestational age a risk factor for retinopathy of prematurity? A study with 345 very low birth weight preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Neonatal outcomes of small for gestational age preterm infants in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Serum Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in the Human Fetus. Relationships with Growth in Normal Subjects and in Subjects with Intrauterine Growth Retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Early nutrition impact on the insulin-like growth factor axis and later health consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Gene expression patterns of insulin-like growth factor 1, 2 (IGF-1, IGF-2) and insulin-like growth factor binding protein 3 (IGFBP-3) in human placenta from preterm deliveries: influence of additional factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Postnatal Decrease in Circulating Insulin-Like Growth Factor-I and Low Brain Volumes in Very Preterm Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Experimental approach to the pathogenesis of retrolental fibroplasia. III. Changes in the eye induced by exposure of newborn mice to general hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Hyperglycemia and retinopathy of prematurity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Influence of Insulin-Like Growth Factor I and Nutrition During Phases of Postnatal Growth in Very Preterm Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Candida sepsis and association with retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Neonatal bacteremia and retinopathy of prematurity: the ELGAN study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Immaturity, perinatal inflammation, and retinopathy of prematurity: A multi-hit hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Inflammation and retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Perinatal systemic inflammatory response syndrome and retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The apparent role of blood transfusions in the development of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Genetic susceptibility to advanced retinopathy of prematurity (ROP)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The clustering of disorders in infants born before the 28th week of gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Impact at age 11 years of major neonatal morbidities in children born extremely preterm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The International Classification of Retinopathy of Prematurity revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Screening examination of premature infants for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Screening examination of premature infants for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The early postnatal weight gain as a predictor of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

A predictive score for retinopathy of prematurity in very low birth weight preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Review of the use of digital imaging in retinopathy of prematurity screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Risk analysis of prethreshold retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

1 reference

7 January 2021

Experts do not agree when to treat retinopathy of prematurity based on plus disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Comparison of expert graders to computer-assisted image analysis of the retina in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP): 36-month experience with telemedicine screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Temporary morphological changes in plus disease induced during contact digital imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Grating visual acuity results in the early treatment for retinopathy of prematurity study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Ophthalmological problems of the premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Deactivation of the rod response in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: a study of refractive status at 7 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Long-term evaluation of refractive status and optical components in eyes of children born prematurely.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Cerebral damage may be the primary risk factor for visual impairment in preschool children born extremely premature.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

IGF-I is critical for normal vascularization of the human retina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Serum levels of IGF1 are a useful predictor of retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Intravitreal bevacizumab for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Are we there yet? Bevacizumab therapy for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

On the use of antiangiogenetic medications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Inositol for respiratory distress syndrome in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

D-Penicillamine for preventing retinopathy of prematurity in preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960178-6

7 January 2021

Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity.

1 reference

12 December 2020

Oxygen-induced retinopathy in the mouse

1 reference

12 December 2020

Erythropoietin deficiency decreases vascular stability in mice.

1 reference

12 December 2020

An international classification of retinopathy of prematurity

1 reference

12 December 2020

The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors

1 reference

12 December 2020

Variable oxygen exposure causes preretinal neovascularization in the newborn rat

1 reference

12 December 2020

Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach

1 reference

12 December 2020

The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats

1 reference

12 December 2020